Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Expert Opinion on Therapeutic Patents|August 7, 2012
Pyrazine derivatives: a patent review (2008 - present)Sabrina Baptista Ferreira, Carlos Roland KaiserJournal of Ethnopharmacology|June 15, 2016
Recent trends in phytochemistry, ethnobotany and pharmacological significance of Alchornea cordifolia (Schumach. & Thonn.) Muell. ArgPone Kamdem Boniface, Sabrina Baptista Ferreira, Carlos Roland KaiserJournal of Ethnopharmacology|May 25, 2017
Current state of knowledge on the traditional uses, phytochemistry, and pharmacology of the genus HymenaeaPone Kamdem Boniface, Sabrina Baptista Ferreira, Carlos Roland KaiserViruses|March 28, 2024
Recent Advances on Targeting Proteases for Antiviral DevelopmentPedro Henrique Oliveira Borges, Sabrina Baptista Ferreira, Floriano Paes SilvaOrganic & Biomolecular Chemistry|September 15, 2010
Strategies for the synthesis of bioactive pyran naphthoquinonesVitor Francisco Ferreira, Sabrina Baptista Ferreira, Fernando de Carvalho da SilvaThe Enzymes|November 14, 2025
Hepatitis C virus (HCV) proteases: structure, function and inhibition strategiesPedro Henrique Oliveira Borges, Emmanuel Gras, Sabrina Baptista Ferreira, et al.Cancer Cell International|August 8, 2019
The diverse mechanisms and anticancer potential of naphthoquinonesCarolina Escardó Pereyra, Rafael Ferreira Dantas, Sabrina Baptista Ferreira, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|July 23, 2021
Development of tacrine clusters as positively cooperative systems for the inhibition of acetylcholinesteraseTereza Cristina Santos Evangelista, Óscar López, Sabrina Baptista Ferreira, et al.Chembiochem : a European Journal of Chemical Biology|July 4, 2012
Kinetics studies on the inhibition mechanism of pancreatic α-amylase by glycoconjugated 1H-1,2,3-triazoles: a new class of inhibitors with hypoglycemiant activityMario Roberto Senger, Lucas da Costa Andrade Gomes, Sabrina Baptista Ferreira, et al.Expert Opinion on Drug Discovery|August 17, 2019
Dealing with frequent hitters in drug discovery: a multidisciplinary view on the issue of filtering compounds on biological screeningsRafael Ferreira Dantas, Tereza Cristina Santos Evangelista, Bruno Junior Neves, et al.Pageof 3